CD19 and acute lymphoblastic leukemia: In contrast, Rabilloud et al. dissected one case of CD19-negative ALL relapse after CAR with the help of scRNA-seq, and could show that this was due to the expression of a non-functional CD19 isoform in ALL cells, which were detectable even prior to CAR T cell therapy.